JVM Co

JVM Co Net Margin

The Net Profit Margin of JVM Co (054950.KQ) as of Nov 4, 2026 is 16.38 %. In the previous year, Net Profit Margin was 18.09 % — a change of -9.49% (lower).

Net Margin

16.38 %

YoY

-9.49%

Last updated:

Net Profit Margin of JVM Co is 2025 16.38 % . Net Profit Margin of JVM Co was 2024 18.09 % . It decreases by -9.49% lower compared to the previous year.

JVM Co's net margin stands at 16.4%, up from 7.7% several years earlier.

The JVM Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
7.87 KRW
Jan 1, 2019
5.27 KRW
Jan 1, 2020
9.05 KRW
Jan 1, 2021
7.73 KRW
Jan 1, 2022
11.10 KRW
Jan 1, 2023
16.71 KRW
Jan 1, 2024
18.09 KRW
Jan 1, 2025
16.38 KRW
The JVM Co Net Margin history
YEARNet MarginYoY
16.38 %-9.49%
18.09 %+8.29%
16.71 %+50.54%
11.10 %+43.61%
7.73 %-14.59%
9.05 %+71.81%
5.27 %-33.11%
7.87 %-27.06%
10.79 %-4.55%
11.31 %+91.78%
5.90 %-48.54%
11.46 %+6,121.31%
0.18 %+119.17%
0.08 %-49.35%
0.17 %+54.42%
0.11 %-78.06%
0.49 %-133.52%
-1.46 %-593.73%
0.30 %-12.16%
0.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Net Profit Margin of JVM Co is 16.38 % in 2025.

Net Profit Margin of JVM Co changed from 18.09 % to 16.38 %, representing a -9.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin JVM Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JVM Co

All Key Metrics — JVM Co